The last ten years have seen a notable increase in balloon pulmonary angioplasty safety.

Getting Through the Door: How COPD, Lung Cancer Screening Remains Minimal

Getting Through the Door: How COPD, Lung Cancer Screening Remains Minimal

Advancing NP and PA Involvement in Pulmonary Care, CHEST Learning Susan Corbridge, PhD, Alanna Kavanugh, MSN, CCRN

Susan Corbridge, PhD, and Alanna Kavannagh, MSN, CCRN, discuss the role of advanced practice providers on the evolving pulmonary and critical care teams during CHEST 2025.

Thunderstorms Linked to Surge in Asthma ER Visits

Thunderstorms Linked to Surge in Asthma ER Visits

House Dust Mite SLIT Tablet Well Tolerated in Children With Allergic Asthma

House Dust Mite SLIT Tablet Well Tolerated in Children With Allergic Asthma

5 Pulmonology Headlines You Missed in November 2025

5 Pulmonology Headlines You Missed in November 2025

Nalbuphine Extended-Release Reduces Chronic Cough in IPF, with Philip Molyneaux, MBBS Philip Molyneaux, MBBS

Pulmonary Rehabilitation Reduces Type 2 Inflammation in High Inflammation Asthma

Pulmonary Rehabilitation Reduces Type 2 Inflammation in High Inflammation Asthma

Achieving Clinical Remission in Asthma Care, With Linda Rogers, MD Linda Rogers, MD

Roger discusses how new therapies are transforming asthma treatment, enabling potential clinical remission.

Rewriting Airway Disease With Trait-Based Care: 2025’s Convergence of Asthma and COPD Management

Rewriting Airway Disease With Trait-Based Care: 2025’s Convergence of Asthma and COPD Management

Tezepelumab Drastically Reduces OCS Use for Asthma in Open-Label Trial

Tezepelumab Drastically Reduces OCS Use for Asthma in Open-Label Trial

How to Set a Biologic Strategy for Asthma, with Sara Assaf, MD Sara Assaf, MD

Assaf shares insights into how to navigate patient profiles and treatment options to optimize severe asthma care with biologics.

Exploring the New COPD Era: Biologics, Guidelines, and Real-World Barriers

Exploring the New COPD Era: Biologics, Guidelines, and Real-World Barriers

Long-Term Data Support New Zopapogene Imadenovec Approval for RRP Victoria Johnson

New long-term data reveals that Papzimeos offers sustained relief for adults with recurrent respiratory papillomatosis, reducing the need for surgeries.

Lungcast: Resilience and Sustainability: Preparing Healthcare for the Future with Elizabeth Cerceo, MD Albert Rizzo, MD, Elizabeth Cerceo, MD

This episode of Lungcast features a discussion on emerging treatment approaches for SCLC.

FDA Accepts NDA for Chiesi’s Single Inhaler Triple Therapy for Asthma Victoria Johnson

The therapy is currently approved in almost 50 countries under the name Trimbow.

Mucoactives Found to Have Little Benefit for Bronchiectasis Victoria Johnson

A recent study reveals that hypertonic saline and carbocisteine do not effectively reduce pulmonary exacerbations.